Nalaganje...

Meta-analysis of gemcitabine in brief versus prolonged low-dose infusion for advanced non-small cell lung cancer.

OBJECTIVE:To evaluate the efficacy and safety of gemcitabine (GEM) at 30 min standard-dose infusion (30 min-SDI) compared with prolonged low-dose infusion (P-LDI) in patients with advanced non-small-cell lung cancer (NSCLC). METHODS:Electronic databases including Pubmed, EMbase, Cochrane Library, CN...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Zhao Dehua, Chu Mingming, Wang Jisheng
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science (PLoS) 2018-01-01
Serija:PLoS ONE
Online dostop:http://europepmc.org/articles/PMC5862432?pdf=render
Oznake: Označite
Brez oznak, prvi označite!